VANCOUVER, BC, Nov. 14, 2024 /CNW/ - GR Silver Mining Ltd. ("GR Silver Mining" or the "Company") (TSXV: GRSL) (OTCQB: GRSLF) (FRANKFURT: GPE) is pleased...

- PARADIGM ™ program comprises two 12-week randomized, placebo-controlled studies (APPROACH and EMBRACE) and a long-term extension study (EXTEND) - - APPROACH ™ : A P hase...

Gilead Sciences is implementing a strategic restructuring, including workforce reductions at its Kite Pharma subsidiary and the closure of its...

Fresh off the successful $1.25 billion acquisition of Yellow Jersey Therapeutics by Johnson & Johnson, Kaken Pharmaceutical and Numab Therapeutics...

Drug delivery specialist Halozyme Therapeutics has launched a $2.1 billion (€2 billion) takeover bid for Evotec, a leading drug discovery...

Riding the wave of success from Johnson & Johnson's acquisition of Yellow Jersey Therapeutics, Kaken Pharmaceutical and Numab Therapeutics are...

A bombshell report from Science and a subsequent NIH investigation have revealed extensive evidence of research misconduct by Dr. Eliezer...